Peer Review reports
From: IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients
| Original Submission | ||
|---|---|---|
| 16 Nov 2023 | Submitted | Original manuscript |
| 9 Dec 2023 | Reviewed | Reviewer Report |
| 11 Dec 2023 | Reviewed | Reviewer Report - Anna Vanni |
| 25 Dec 2023 | Author responded | Author comments - Dongfeng Zeng |
| Resubmission - Version 2 | ||
| 25 Dec 2023 | Submitted | Manuscript version 2 |
| 26 Dec 2023 | Author responded | Author comments - Dongfeng Zeng |
| Resubmission - Version 3 | ||
| 26 Dec 2023 | Submitted | Manuscript version 3 |
| 26 Dec 2023 | Author responded | Author comments - Dongfeng Zeng |
| Resubmission - Version 4 | ||
| 26 Dec 2023 | Submitted | Manuscript version 4 |
| 26 Dec 2023 | Author responded | Author comments - Dongfeng Zeng |
| Resubmission - Version 5 | ||
| 26 Dec 2023 | Submitted | Manuscript version 5 |
| 28 Dec 2023 | Reviewed | Reviewer Report |
| 2 Jan 2024 | Reviewed | Reviewer Report - Anna Vanni |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 2 Jan 2024 | Editorially accepted | |
| 13 Jan 2024 | Article published | 10.1186/s12865-024-00596-1 |
You can find further information about peer review here.